One of the most striking aspects of the congress was the pace of innovation across every area of urology. From conversations on the exhibition floor to insights shared during scientific sessions, there was a clear sense that the field is moving steadily toward more precise, patient-centred care. In particular, developments continued refinement and evolution of endourology and urolithiasis care. Alongside this, imaging and diagnostics continue to evolve at an impressive rate. New technologies are enabling earlier and more accurate detection of disease, which in turn supports more personalised treatment decisions. It was encouraging to see how these innovations are no longer theoretical but increasingly being integrated into clinical practice.

Minimally invasive and image-guided therapies were another consistent theme throughout the event. Live and recorded procedural sessions highlighted how far techniques have progressed, with a strong focus on precision, recovery times, and overall patient experience. The shift toward less invasive approaches is clearly not just a trend, but a fundamental change in how urological care is delivered.

Beyond the science and technology, what made the experience particularly valuable for us was the opportunity to connect face-to-face with our urology partners. These conversations gave us a deeper understanding of the challenges clinicians are facing in real-world settings, as well as the opportunities to work together more closely. There is something uniquely powerful about being able to exchange ideas in person, and events like EAU continue to play a vital role in strengthening those relationships.

Leaving London, there was a strong sense that urology is entering an exciting phase, one defined by greater precision, better use of data, and closer collaboration across the healthcare ecosystem. The insights we gained and the discussions we had will directly inform how we continue to support our customers moving forward.

Overall, our time at EAU 2026 was both energising and thought-provoking. It reinforced the importance of staying connected to the wider urology community and remaining engaged with the innovations that are shaping the future of patient care. We are pleased to offer our full stone mangement solution The-Complete-Stone-Management-Solution-from-HSL-V6.pdf

The post Reflections from EAU 2026: Advancing the Future of Urology Through Collaboration and Innovation appeared first on Hospital Services Limited UK.

HSL, with a legacy of supporting healthcare professionals, specialises in providing cutting-edge medical technologies and services that improve clinical workflows, enhance patient outcomes, and optimise operational efficiencies. By joining AXREM, HSL strengthens its ability to contribute to critical conversations around healthcare technology, regulations, and the digital transformation of healthcare.

AXREM plays a pivotal role in fostering collaboration between industry suppliers, the NHS, and private healthcare providers. Its mission is to address shared challenges and deliver meaningful improvements across the sector while advocating for fair and effective procurement practices.

As an AXREM member, HSL is excited to participate in key focus groups, leveraging its expertise in medical imaging, healthcare IT, and clinical support to contribute to the industry-wide goal of enhancing patient care and healthcare delivery.

Dominic Walsh CEO of HSL, commented:
“Joining AXREM is a significant step forward for HSL. This partnership enables us to work collaboratively with like-minded organisations to drive technological advancements that directly benefit healthcare professionals and patients. We are passionate about supporting the NHS in achieving its goals for better patient care, improved efficiency, and reduced costs. AXREM’s vision aligns perfectly with ours, and we are eager to contribute to its initiatives and learn from the expertise of other members.”

Sally Edgington, Chief Executive Officer of AXREM, added:
“I am really excited and pleased to welcome HSL to AXREM Membership, this is great timing as we have recently published our Strategic Priorities 2025-27 and appointed a new Chair, so there will be a lot of strategic activities over the coming months, which I know HSL will be able to input into and influence. Being part of an industry group like AXREM is key to suppliers enabling them to horizon scan the market, have meaningful government engagement and be at the forefront of influencing policy. I am looking forward to working with the HSL team over the coming weeks and months”.

About HSL
HSL is a leading provider of medical technologies, clinical solutions, and healthcare IT services across the UK and Ireland. With a commitment to improving healthcare delivery, HSL partners with global innovators to bring the best technologies to hospitals and clinics, ensuring exceptional patient outcomes and operational efficiency.

About AXREM
AXREM represents suppliers of diagnostic medical imaging, radiotherapy, healthcare IT, and care equipment in the UK. Its members are committed to improving patient care through innovation, collaboration, and advocacy. AXREM provides a platform for addressing industry-wide challenges, promoting best practices, and driving advancements in healthcare technology. For more information, visit www.axrem.org.uk

The post HSL Joins AXREM, Reinforcing Its Commitment to Advancing UK Healthcare Technology appeared first on Hospital Services Limited UK.